Table 3.
Correlation of the TSIA assay (continuous and short exposure) with accumulation of MTX polyglutamates and TS mRNA expression
| Precursor B cell ALL | T cell ALL | Total ALL | ||||
|---|---|---|---|---|---|---|
| TSIA cont. | TSIA short | TSIA cont. | TSIA short | TSIA cont. | TSIA short | |
| MTX-Glu1–6 | ||||||
| Correlation coefficient | −0.547* | −0.495* | −0.094 | −0.128 | −0.432* | −0.524* |
| P value | <0.001 | <0.001 | 0.685 | 0.612 | <0.001 | <0.001 |
| Number of patients | 64 | 58 | 21 | 18 | 85 | 76 |
| MTX-Glu4–6 | ||||||
| Correlation coefficient | −0.494* | −0.503* | −0.258 | 0.046 | −0.399* | −0.568* |
| P value | <0.001 | <0.001 | 0.336 | 0.875 | 0.001 | <0.001 |
| Number of patients | 54 | 50 | 16 | 14 | 70 | 64 |
| TS mRNA | ||||||
| Correlation coefficient | 0.591 | 0.678* | 0.139 | 0.483 | 0.466* | 0.693* |
| P value | 0.056 | 0.045 | 0.701 | 0.187 | 0.033 | 0.001 |
| Number of patients | 11 | 9 | 10 | 9 | 21 | 18 |
P value was estimated using Spearman’s Rho test; TSIA continuous (TSIA cont.) and short-term exposure (TSIA short) are expressed as the concentration of MTX (in μM) necessary to inhibit 50 % of the TS activity (TSI50) compared to the controls incubated without MTX (in triplicate); the concentration of MTX polyglutamates (MTX-Glu1–6 and MTX-Glu4–6) is expressed as pmol MTX-Glun/109 cells; TS mRNA level is expressed as ratio normalized to β-actin. The asterisk denotes significant (P < 0.05) associations